EUVIMEDEUVIMED entdecken
Crossref

Optimizing the Distribution of Ablation Lesions to Prevent Postablation Atrial Tachycardia

Kensuke Sakata, Ryan P Bradley, Adityo Prakosa, Carolyna A P Yamamoto, Syed Yusuf Ali, Shane Loeffler, Eugene G Kholmovski, Sunil Kumar Sinha, Joseph E Marine, Hugh Calkins, David D Spragg, Natalia A Trayanova

JACC: Clinical Electrophysiology · 2024-11 · 10 (11) · 2347-2358

DOI: 10.1016/j.jacep.2024.07.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2024-11. Verfasst von Kensuke Sakata und 11 weiteren Autor:innen. Beteiligte Einrichtung: Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: NHLBI NIH HHS, Johns Hopkins University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although targeting atrial fibrillation (AF) drivers and substrates has been used as an effective adjunctive ablation strategy for patients with persistent AF (PsAF), it can result in iatrogenic scar-related atrial tachycardia (iAT) requiring additional ablation. Personalized atrial digital twins (DTs) have been used preprocedurally to devise ablation targeting that eliminate the fibrotic substrate arrhythmogenic propensity and could potentially be used to predict and prevent postablation iAT. OBJECTIVES: In this study, the authors sought to explore possible alternative configurations of ablation lesions that could prevent iAT occurrence with the use of biatrial DTs of prospectively enrolled PsAF patients. METHODS: Biatrial DTs were generated from late gadolinium enhancement-magnetic resonance images of 37 consecutive PsAF patients, and the fibrotic substrate locations in the DT capable of sustaining reentries were determined. These locations were ablated in DTs by representing a single compound region of ablation with normal power (SSA), and postablation iAT occurrence was determined. At locations of iAT, ablation at the same DT target was repeated, but applying multiple lesions of reduced-strength (MRA) instead of SSA. RESULTS: Eighty-three locations in the fibrotic substrates of 28 personalized biatrial DTs were capable of sustaining reentries and were thus targeted for SSA ablation. Of these ablations, 45 resulted in iAT. Repeating the ablation at these targets with MRA instead of SSA resulted in the prevention of iAT occurrence at 15 locations (18% reduction in the rate of iAT occurrence). CONCLUSIONS: Personalized atrial DTs enable preprocedure prediction of iAT occurrence after ablation in the fibrotic substrate. It also suggests MRA could be a potential strategy for preventing postablation AT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationHumansFemaleMaleMiddle AgedAgedMagnetic Resonance ImagingHeart AtriaProspective StudiesTachycardia, Supraventricular

Stichwörter der Autor:innen

ablationatrial fibrillationdigital twinfibrotic substrateiatrogenic atrial tachycardia

Autor:innen und Institutionen

  • Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland, USA.
  • Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland, USA; Research Computing, Lehigh University, Bethlehem, Pennsylvania, USA.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
  • Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland, USA; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
  • Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland, USA; Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA. Electronic a…

Förderung

  • NHLBI NIH HHS
  • Johns Hopkins University

Zitieren

APA

Sakata, K., Bradley, R. P., Prakosa, A., Yamamoto, C. A. P., Yusuf Ali, S., Loeffler, S., Kholmovski, E. G., Kumar Sinha, S., Marine, J. E., Calkins, H., Spragg, D. D., & Trayanova, N. A. (2024). Optimizing the Distribution of Ablation Lesions to Prevent Postablation Atrial Tachycardia. JACC: Clinical Electrophysiology, 10(11), 2347-2358. https://doi.org/10.1016/j.jacep.2024.07.002

Vancouver

Sakata K, Bradley RP, Prakosa A, Yamamoto CAP, Yusuf Ali S, Loeffler S, et al. Optimizing the Distribution of Ablation Lesions to Prevent Postablation Atrial Tachycardia. JACC: Clinical Electrophysiology. 2024;10(11):2347-2358. doi:10.1016/j.jacep.2024.07.002

BibTeX
@article{Sakata2024,
  author = {Sakata, Kensuke and Bradley, Ryan P and Prakosa, Adityo and Yamamoto, Carolyna A P and Yusuf Ali, Syed and Loeffler, Shane and Kholmovski, Eugene G and Kumar Sinha, Sunil and Marine, Joseph E and Calkins, Hugh and Spragg, David D and Trayanova, Natalia A},
  title = {Optimizing the Distribution of Ablation Lesions to Prevent Postablation Atrial Tachycardia},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  volume = {10},
  number = {11},
  pages = {2347--2358},
  doi = {10.1016/j.jacep.2024.07.002}
}
Kostenlos starten →